成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

CD40穩(wěn)定細(xì)胞系,CD40 Stable Cell Line
  • CD40穩(wěn)定細(xì)胞系,CD40 Stable Cell Line
  • CD40穩(wěn)定細(xì)胞系,CD40 Stable Cell Line
  • CD40穩(wěn)定細(xì)胞系,CD40 Stable Cell Line

CD40穩(wěn)定細(xì)胞系/細(xì)胞株-ACROBiosystems百普賽斯

價(jià)格 詢價(jià)
包裝 1瓶 2瓶 10瓶
最小起訂量 1瓶
發(fā)貨地 北京
更新日期 2024-10-29
微信洽談

產(chǎn)品詳情

中文名稱:CD40穩(wěn)定細(xì)胞系英文名稱:CD40 Stable Cell Line
品牌: 百普賽斯產(chǎn)地: 北京
保存條件: Frozen in liquid nitrogen純度規(guī)格: 99.9%
產(chǎn)品類別: 細(xì)胞株/細(xì)胞系
別名: CD40 Stable Cell Line貨號(hào): CD40 Stable Cell Line
用途范圍: 生物是否進(jìn)口:
2024-10-29 CD40穩(wěn)定細(xì)胞系 CD40 Stable Cell Line 1瓶/RMB;2瓶/RMB;10瓶/RMB 百普賽斯 北京 Frozen in liquid nitrogen 99.9% 細(xì)胞株/細(xì)胞系

Human CD40 (Luc) HEK293 Reporter Cell

描述(Description

The Human CD40 (Luc) HEK293 Reporter Cell was engineered to not only express NF-κB signaling response element, but also express the receptor full length human CD40 (Gene ID: 958), which can drive luciferase expressing systems by CD40 ligand/ agonist antibody stimulation. In the absence of agonist antibody or CD40 ligand, the CD40 receptor is not activated and luminescence signal is low. In the presence of agonist antibody or CD40 ligand, the CD40 pathway-activated luminescence can be detected in a dose-dependent manner. This reporter cell can also be used to test agonist antibody whether in an FcγR-dependent manner to strengthen the agonistic activity.

應(yīng)用說(shuō)明(Application

Screen for ligands or agonist antibodies that can bind and activate CD40.

1.jpg

生長(zhǎng)特性(Growth Properties

Adherent

篩選標(biāo)記(Selection Marker

Puromycin (2 μg/mL) + Hygromycin (20 μg/mL)

培養(yǎng)基(Culture Medium

DMEM medium + 10% FBS

凍存液(Freeze Medium

Serum-free cell cryopreservation medium

裝量(Quantity

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

存儲(chǔ)(Storage

Frozen in liquid nitrogen.

支原體檢測(cè)(Mycoplasma Testing

Negative

無(wú)菌檢測(cè)(Sterility Testing

Negative

使用說(shuō)明(Instructions for Use

See data sheet for detailed culturing and assay protocol.

2.jpg

3.jpg

背景(Background

CD40 is also known as TNFRSF5, Bp50, CDW40, MGC9013, TNFRSF5 and p50, is a member of the TNF receptor superfamily which are single transmembrane-spanning glycoproteins, and plays an essential role in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. CD40 is a costimulatory protein found on antigen presenting cells and is required for their activation. The binding of CD154 (CD40L) on TH cells to CD40 activates antigen presenting cells and induces a variety of downstream effects. CD40 contains 4 cysteine-rich repeats in the extracellular domain, and is expressed in B cells, dendritic cells, macrophages, endothelial cells, and several tumor cell lines. The extracellular domain has the cysteinerich repeat regions, which are characteristic for many of the receptors of the TNF superfamily. Interaction of CD40 with its ligand, CD40L, leads to aggregation of CD40 molecules,which in turn interact with cytoplasmic components to initiate signaling pathways. Early studies on the CD40-CD40L system revealed its role in humoral immunity. Defects in CD40 result in hyper-IgM immunodeficiency type 3 (HIGM3), an autosomal recessive disorder characterized by an inability of B cells to undergo isotype switching, as well as an inability to mount an antibody-specific immune response, and a lack of germinal center formation.

Permits & Restrictions

This cell line is provided for research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. You are not allowed to share, distribute, sell, modify, sublicense, or otherwise make this cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. AcroBiosystems does not warrant the suitability of this cell line for any particular use, and does not accept any liability in connection with the handling or use of this cell line.

關(guān)鍵字: CD40穩(wěn)定細(xì)胞系;CD40細(xì)胞系;CD40細(xì)胞株;ACRO;百普賽斯;

公司簡(jiǎn)介

百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。
成立日期 2010-07-22 (15年) 注冊(cè)資本 8000萬(wàn)人民幣
員工人數(shù) 500人以上 年?duì)I業(yè)額 ¥ 1億以上
主營(yíng)行業(yè) 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 經(jīng)營(yíng)模式 工廠,試劑
  • 北京百普賽斯生物科技股份有限公司
VIP 1年
  • 公司成立:15年
  • 注冊(cè)資本:8000萬(wàn)人民幣
  • 企業(yè)類型:其他股份有限公司(上市)
  • 主營(yíng)產(chǎn)品:重組蛋白,抗原,抗體,試劑盒
  • 公司地址:北京市北京經(jīng)濟(jì)技術(shù)開發(fā)區(qū)宏達(dá)北路8號(hào)4幢4層
詢盤

CD40穩(wěn)定細(xì)胞系/細(xì)胞株-ACROBiosystems百普賽斯相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
湖北艾普蒂生物工程有限公司
2024-05-16
詢價(jià)
VIP5年
上海惠誠(chéng)生物科技有限公司
2024-11-07
¥1800
VIP1年
上海晶風(fēng)生物科技有限公司
2024-11-07
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的